OMB Approval
 
 
OMB Number:          3235-0167
Expires:                 May 31, 2021
Estimated average burden
hours per response    1.50

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
 
  FORM 15
 
CERTIFICATION AND NOTICE OF TERMINATION OF REGISTRATION UNDER SECTION 12(g) OF THE SECURITIES EXCHANGE ACT OF 1934 OR SUSPENSION OF DUTY TO FILE REPORTS UNDER SECTIONS 13 AND 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934.
 
C ommission File Number :  001-37861
 
MabVax Therapeutics Holdings, Inc.
(Exact name of registrant as specified in its charter)
 
11535 Sorrento Valley Road, Suite 400, San Diego, CA 92121
Telephone: (858) 259-9405  
(Address, including zip code, and telephone number, including area code, of registrant’s principal executive offices)

Common Stock
(Title of each class of securities covered by this Form)
 
None
(Titles of all other classes of securities for which a duty to file reports under section 13(a) or 15(d) remains)
 
 
Please place an X in the box(es) to designate the appropriate rule provision(s) relied upon to terminate or suspend the duty to file reports:
 
Rule12g-4(a)(1)        
☒
Rule12g-4(a)(2)       
☐
Rule12h-3(b)(1)(i)   
☐
Rule12h-3(b)(1)(ii)  
☐
Rule15d-6                
☐
Rule15d-22(b)
☐
 
Approximate number of holders of record as of the certification or notice date: 99
 
Pursuant to the requirements of the Securities Exchange Act of 1934 (Name of registrant as specified in charter) has caused this certification/notice to be signed on its behalf by the undersigned duly authorized person.
 
 
  Date: March 29, 2019
  By: /s/ J. David Hansen